Q-omics provides the consensus-scored RPL36AP55 profile across patient tissues and cancer cell-line models. RPL36AP55 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in DLBC. Additionally, RPL36AP55 RNA expression shows 5,371 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight DLBC, and STAD as cancer lineages where RPL36AP55 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.